Abstract
In October 1997, after a preparatory phase of 8 years, the first patient in Europe was treated by BNCT at the High Flux Reactor (HFR) of the European Commission in Petten, The Netherlands.1 The preparation for the first clinical BNCT trial in Europe included comprehensive scientific experimental and human investigations with the boron compound borocaptate sodium (BSH).2,3 A multitude of open legal and administrative questions had to be overcome. Furthermore a complex structure had to be organized and the procedures had to be defined how to perform a multi-national, multi-institutional study using a nuclear reactor distant from hospital for patient treatment performed by an international team on a multidisciplinary base.4 The international standards of clinical research as well as the accepted rules and definitions of conventional radiotherapy were applied, involving independent experts in order to assure the quality of the study and the quality of the Performance of patient treatment. The goal was to execute the project to a very high Standard as would be expected in the leading radiotherapy depart-ments in Europe.5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
European Organization for Research and Treatment of Cancer (EORTC) BNCT-Study Group. Postoperative Treatment of Glioblastoma with BNCT at the Petten Irradiation Facility. EORTC-Protocol 11961, EORTC, Brussels, 1997.
D. Gabel, D. Preusse, D. Haritz, F. Grochulla, K. Haselsberger, H. Fankhauser, C. Ceberg, H.-D. Peters, and U. Klotz, “Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumors as prerequisite for a phase I clinical trial of boron neutron capture,” Acta Neurochirurgica (Wien), 139:606–612, 1997.
K. Philipp, R. Huiskamp, J. Casado, and R.L. Moss, “Normal tissue tolerance and fractionation effects in dogs of boron neutron capture irradiation with borocaptate sodium (BSH).” In: Y. Mishima (Ed.), Cancer neutron capture therapy, Plenum Press, New York and London, pp. 809–814, 1996.
W. Sauerwein. The clinical project at HFR Petten-a status report. In: B. Larsson, J. Crawford, and R. Weinreich (Eds.) Advances in Neutron Capture Therapy. Volume I, Medicine and Physics. Elsevier Science B.V. Amsterdam 77–82, 1997.
W. Sauerwein, R.L. Moss, J. Rassow, F. Stecher-Rasmussen, K. Hideghéty, S. Garbe, J.G. Wolbers, D. Gabel, P. Watkins, C. Vroegindeweji, and H. Sack. Quality Management at the European BNCT Center in Petten. In: M.F. Hawthorne, K. Shelly, R.W. Wiersema, (Eds.), “Frontiers in Neutron Capture Therapy,” Kluwer Academic/Plenum Publishers, New York, 2001, pp. 105–111.
W. Sauerwein, K. Hideghéty, M. de Vries, J. Wanders, D. Gabel, H. Fankhauser, and R. Huiskamp. Conducting phase I clinical trial in binary treatment modality methodical questions for the evaluation of boron neutron capture therapy, Annals of Oncology Vol., 9, Suppl. 2. 1998.
R.L. Moss, F. Stecher-Rasmussen, K. Ravensberg, G. Constantine, and P. Watkins. Design, Construction, and Installation of an Epithermal Neutron Beam for BNCT at the High Flux Reactor at Petten. In: B.J. Allen, D.E. Moore, and B.V. Harrington (Eds.) Progress in Neutron Capture Therapy for Cancer, Plenum Press, New York, pp. 63–66, 1992.
D. Gabel, and W. Sauerwein. Approaching Clinical Trials of Boron Neutron Capture Therapy in Europe. In: H.D. Kogelnik, (Ed.), Progress in Radio-Oncology. Monduzzi Editore, Bologna, pp. 315–319, 1995.
W. Sauerwein, K. Hideghéty, D. Gabel, and R. Moss. European clinical trials of boron neutron capture therapy for glioblastoma. Nuclear News 41:54–56.
K. Hideghéty, W. Sauerwein, M. de Vries, F. Grochulla, C. Goetz, K. Haselsberger, P. Pacquis, J. Heimans, J. Wolbers, R. Moss, R. Huiskamp, F. Stecher-Rasmussen, J. Rassow, S. Garbe, H. Fankhauser, and D. Gabel. Report on the first patient group of the European phase I trial (EORTC Protocol 11961) at the High Flux Reactor Petten. In: M.F. Hawthorne, K. Shelly, R.W. Wiersema, (Eds.), “Frontiers in Neutron Capture Therapy,” Kluwer Academic/Plenum Publishers, New York, 2001, pp. 105–111.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sauerwein, W. et al. (2001). Status Report on the European Clinical Trial of BNCT at Petten (EORTC Protocol 11961). In: Hawthorne, M.F., Shelly, K., Wiersema, R.J. (eds) Frontiers in Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1285-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1285-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5478-9
Online ISBN: 978-1-4615-1285-1
eBook Packages: Springer Book Archive